Hyperbaric oxygen for thinking, mental health, and quality of life in veterans

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional study gives enrolled veterans a course of hyperbaric oxygen therapy and measures cognitive function, PTSD, depression, anxiety, and quality of life before and after treatment. Participants must be adults with a clinical diagnosis of mild TBI, PTSD, anxiety, or depression, have completed baseline cognitive and psychological measurements, and have previously undergone trauma-focused therapy. Outcomes will be compared pre- and post-treatment and analyzed with statistical control for demographic characteristics. The protocol is conducted at a single commercial site (Summit Hyperbarics and Wellness) in Boise, Idaho.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. At least 18 years of age.
2. Veteran status
3. Clinically diagnosed with a mTBI, PTSD, Anxiety, or Depression disorder by meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and by a qualified and trained professional.
4. The subject is willing and able to read, understand, and sign an informed consent. Additionally, the subject has clear consciousness and the ability to express self-feelings independently.
5. Exposed to at least one trauma-focused therapy or evidence-based psychotherapeutic treatment, such as prolonged exposure therapy, EMDR, or CBT, to name a few.
6. Completed cognitive and psychological measurements.
7. Clinical diagnoses cause significant impairment in social or occupational functioning or some other functional capacity.
8. Sexually active female participants of childbearing potential and sexually active male participants with female partners of childbearing potential must agree to use an acceptable method of contraception for the duration of the study and for 30 days following the final HBOT session.
9. Stability on any current psychoactive medications (antidepressants, anti-anxiety medications, antipsychotics, stimulants, and mood stabilizers).

Exclusion Criteria:

1. Untreated pneumothorax
2. History of spontaneous pneumothorax
3. Severe sinus infection
4. Upper respiratory infection
5. Asymptomatic pulmonary lesions on chest x-ray
6. Uncontrollable high fever (greater than 39C)
7. History of chest or ear surgery
8. Congenital spherocytosis
9. Any anemia or blood disorder
10. Any convulsive disorder
11. History of optic neuritis or sudden blindness
12. Middle ear infection
13. Diabetes mellitus (insulin therapy)
14. The subject is pregnant or lactating
15. Nicotine use/substance use/addiction
16. Acute Hypoglycemia
17. Diagnosed Chronic Obstructive Pulmonary Disease (COPD) and Emphysema
18. Presenting with symptoms of cough, congestion, vomiting, diarrhea, or open wounds.
19. Active malignancy
20. Current manic, delusional, or psychotic episodes
21. Serious/current suicidal ideations
22. Severe or unstable physical disorders or major cognitive deficits
23. Inability to attend scheduled clinic visits or comply with study protocols.
24. Treated with HBOT for any reason prior to study enrollment.
25. Non-English speakers
26. History of retinal repair, including laser photocoagulation or retinal detachment surgery.
27. History of middle ear surgery, including tympanoplasty, mastoidectomy, or pressure equalization tube placement.
28. Age greater than 75 years.
29. Use of any of the following medications during the study period: Anti-metabolites (e.g., methotrexate, azathioprine); Chemotherapuetic agents (e.g., cyclophosphamide, cisplatin); Mafenide acetate e.g., Sulfamylon); Disulfiram (e.g, Antabuse); Peripheral vasodilators known to interact with oxygen exposure (e.g., nitroglycerin); and Antibacterial drugs with known HBOT interaction risks.

Where it's running

• Summit Hyperbarics and Wellness
  Boise, Idaho, United States Recruiting

Study contacts

• Principal investigator: Steven Wyman, MD — Summit Hyperbarics and Wellness
• Study coordinator: Troy Nickel, PhD
• Email: tnickel@shwidaho.org
• Phone: 208-813-9541

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury

  This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT07890337

• COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support

  This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.

  Recruiting at 17 sites Phase 2/3 COMPASS Pathways · Tucson, Arizona and 16 other locations · NCT07570654

• Virtual Reality–Assisted Trauma-Focused CBT for PTSD

  A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.

  Recruiting Queen's University, Belfast · Newtownabbey, County Antrim · NCT07914634

• HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

  This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

• Predicting nightmare awakenings in PTSD using an AI algorithm

  The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.

  Recruiting at 2 sites Direction Centrale du Service de Santé des Armées · Brest and 2 other locations · NCT07851480

• Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced

  This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.

  Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07813962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.